- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation.Prostate CancerMarch 31, 2023
-
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.Prostate CancerMarch 31, 2023
-
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.Prostate CancerMarch 31, 2023
-
Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial.Prostate CancerMarch 31, 2023
-
Impact of treatment on elder-relevant physical function and quality of life outcomes in older adults with metastatic castration-resistant prostate cancer.Prostate CancerMarch 31, 2023
-
Is It Safe to Switch from a Standard Anterior to Retzius-Sparing Approach in Robot-Assisted Radical Prostatectomy?Prostate CancerMarch 30, 2023
-
Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study.Prostate CancerMarch 30, 2023
-
Response to RL-225Ac in prostate cancer: effect of prior treatment with RL-177Lu: a systematic review of the literature.Prostate CancerMarch 30, 2023
-
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.Prostate CancerMarch 30, 2023
-
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.Prostate CancerMarch 30, 2023
Beyond the Abstracts
-
Should Transperineal Prostate Biopsy Be the Standard of Care? - Beyond the AbstractProstate CancerMarch 30, 2023
-
Outcomes of Robot-Assisted Radical Prostatectomy with the HUGO RAS Surgical System: Initial Experience at a High-Volume Robotic Center - Beyond the AbstractProstate CancerMarch 28, 2023
-
Comparison of Outcomes in High-Risk Prostate Cancer Patients Treated With Low-/High-Dose-Rate Brachytherapy Plus External Beam Radiotherapy - Beyond the AbstractProstate CancerMarch 27, 2023
-
WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer - Beyond the AbstractProstate CancerMarch 24, 2023
-
A Role for Laparoscopy in the Age of Robotics: A Retrospective Cohort Study of Perioperative Outcomes Between 2D Laparoscopic Radical Prostatectomy vs 3DHD Laparoscopic Radical Prostatectomy - Beyond the AbstractProstate CancerMarch 24, 2023
-
Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases - Beyond the AbstractProstate CancerMarch 22, 2023
-
Response to Bipolar Androgen Therapy and PD-1 Inhibition in a Patient with Metastatic Castration-Resistant Prostate Cancer and a Germline CHEK2 Mutation - Beyond the AbstractProstate CancerMarch 21, 2023
-
Trends in Prostate Cancer Mortality in the United States of America, by State and Race, from 1999 to 2019: Estimates from the Centers for Disease Control WONDER Database - Beyond the AbstractProstate CancerMarch 17, 2023
-
Prostate Cancer Care at Hospital Systems Serving Health Disparity Populations - Beyond the AbstractProstate CancerMarch 13, 2023
-
Variation and Disparity in the Use of Prostate Cancer Risk Stratification Tools in the United States - Beyond the AbstractProstate CancerMarch 6, 2023